Phase 3 Psoriasis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who took part in a previous related study (HB0034-04) and completed at least the Week 12 visit of that study
- People whose doctor considers them a suitable candidate for ongoing long-term treatment for their condition
- Men and women of reproductive age who do not plan to have children and are willing to use reliable contraception throughout the study and for 6 months after the last dose of the study drug
- People who fully understand the study, are willing to sign a consent form, and are able to attend all required study visits and follow-up appointments
Who may not be able to join:
- People who are currently experiencing an active flare-up of their condition at the time of enrolment
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jianzhong Zhang, PhD, Peking University People's Hospital (PKUPH)
Phone: +86 13636638684
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Safety endpoints include the proportion of subjects with TEAEs
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.